Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.

The pseudokinase Trib1 functions as a myeloid oncogene that recruits the E3 ubiquitin ligase COP1 to C/EBPa and interacts with MEK1 to enhance ERK phosphorylation. Close genetic effect of Trib1 on Hoxa9 has been observed in myeloid leukemogenesis where Trib1 overexpression significantly accelerates Hoxa9-induced leukemia onset. However, the mechanism underlying how Trib1 functionally modulates Hoxa9 transcription activity is unclear. Herein, we provide evidence that Trib1 modulates Hoxa9-associated super-enhancers. ChIP-seq analysis identified increased histone H3K27Ac signals at super-enhancers of the Erg, Spns2, Rgl1, and Pik3cd loci, as well as increased mRNA expression of these genes. Modification of super-enhancer activity was mostly achieved via the degradation of C/EBPa p42 by Trib1, with a slight contribution from the MEK/ERK pathway. Silencing of Erg abrogated the growth advantage acquired by Trib1 overexpression, indicating that Erg is a critical downstream target of the Trib1/Hoxa9 axis. Moreover, treatment of acute myeloid leukemia (AML) cells with the BRD4 inhibitor JQ1 showed growth inhibition in a Trib1/Erg-dependent manner both in vitro and in vivo. Upregulation of ERG by TRIB1 was also observed in human AML cell lines, suggesting that Trib1 is a potential therapeutic target of Hoxa9-associated AML. Taken together, our study demonstrates a novel mechanism by which Trib1 modulates chromatin and Hoxa9-driven transcription in myeloid leukemogenesis.

[1]  J. Dick,et al.  An ERG enhancer-based reporter identifies leukemia cells with elevated leukemogenic potential driven by ERG-USP9X feed-forward regulation. , 2019, Cancer research.

[2]  G. Wertheim,et al.  Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program. , 2019, Blood.

[3]  James E. Bradner,et al.  Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. , 2018, Cancer cell.

[4]  S. Raimondi,et al.  Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. , 2018, Blood.

[5]  S. Armstrong,et al.  HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis. , 2018, Cancer cell.

[6]  N. Kannan,et al.  Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1 , 2018, Science Signaling.

[7]  D. Drewry,et al.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells , 2018, Science Signaling.

[8]  H. Aburatani,et al.  EWS‐FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma , 2018, Cancer science.

[9]  Gabriela Alexe,et al.  Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia , 2017, Cancer cell.

[10]  P. Eyers,et al.  Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease , 2017, Trends in cell biology.

[11]  H. Aburatani,et al.  MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis. , 2016, The Journal of clinical investigation.

[12]  B. Porse,et al.  The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia , 2016, Oncogene.

[13]  CT Collins,et al.  Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets , 2016, Oncogene.

[14]  Richard A Young,et al.  Models of human core transcriptional regulatory circuitries , 2016, Genome research.

[15]  Weiwen Dai,et al.  Molecular Mechanism of CCAAT-Enhancer Binding Protein Recruitment by the TRIB1 Pseudokinase. , 2015, Structure.

[16]  Takuro Nakamura.  The role of Trib1 in myeloid leukaemogenesis and differentiation. , 2015, Biochemical Society transactions.

[17]  Marie S. Hasemann,et al.  ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation , 2015, Genes & development.

[18]  Darryl J Pappin,et al.  BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. , 2015, Molecular cell.

[19]  G. Poda,et al.  Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia , 2015, Nature chemical biology.

[20]  B. Göttgens,et al.  The Endothelial Transcription Factor ERG Promotes Vascular Stability and Growth through Wnt/β-Catenin Signaling , 2015, Developmental cell.

[21]  P. D. de Jong,et al.  Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. , 2014, The Journal of clinical investigation.

[22]  D. Beck,et al.  Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias , 2014, Leukemia.

[23]  Y. Ishikawa,et al.  TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression. , 2014, Cancer research.

[24]  J. Hess,et al.  C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis , 2014, Proceedings of the National Academy of Sciences.

[25]  Sridhar Ramaswamy,et al.  Targeting transcription regulation in cancer with a covalent CDK7 inhibitor , 2014, Nature.

[26]  Jae-seok Roe,et al.  C/EBPα: critical at the origin of leukemic transformation , 2014, The Journal of experimental medicine.

[27]  Marie S. Hasemann,et al.  Initiation of MLL-rearranged AML is dependent on C/EBPα , 2014, The Journal of experimental medicine.

[28]  Charles Y. Lin,et al.  Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. , 2013, Cancer cell.

[29]  B. Göttgens,et al.  Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. , 2013, Blood.

[30]  K. Keeshan,et al.  Tribbles in acute leukemia. , 2013, Blood.

[31]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[32]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[33]  Jeffrey L. Wrana,et al.  High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer , 2013, Proceedings of the National Academy of Sciences.

[34]  Gos Micklem,et al.  Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. , 2012, Blood.

[35]  Jiwang Zhang,et al.  Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. , 2012, Cancer cell.

[36]  A. Hero,et al.  Identification and characterization of Hoxa9 binding sites in hematopoietic cells. , 2012, Blood.

[37]  Amanda J. Wilson,et al.  Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. , 2011, Cell stem cell.

[38]  Takuro Nakamura,et al.  Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation , 2011, Cancer science.

[39]  S. Tsuzuki,et al.  Promotion and maintenance of leukemia by ERG. , 2011, Blood.

[40]  Takuro Nakamura,et al.  Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis. , 2010, Blood.

[41]  S. Menéndez,et al.  The oncogenic role of the ETS transcription factors MEF and ERG , 2010, Cell cycle.

[42]  S. Blacklow,et al.  Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia. , 2010, Blood.

[43]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[44]  K. Mimori,et al.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis , 2009, British Journal of Cancer.

[45]  Kenta Nakai,et al.  PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.

[46]  Tina N. Davis,et al.  HOXA9 is required for survival in human MLL-rearranged acute leukemias. , 2009, Blood.

[47]  Ulrich Mansmann,et al.  An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. , 2008, Blood.

[48]  Akihiko Yokoyama,et al.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes. , 2008, Cancer cell.

[49]  Masahiro Iwamoto,et al.  A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. , 2008, Developmental biology.

[50]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[51]  D. Tenen,et al.  Target proteins of C/EBPαp30 in AML: C/EBPαp30 enhances sumoylation of C/EBPαp42 via up-regulation of Ubc9 , 2007 .

[52]  G. Jin,et al.  Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. , 2007, Blood.

[53]  Bas J. Wouters,et al.  Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. , 2006, Cancer cell.

[54]  S. Bohlander,et al.  Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations , 2006, The Journal of experimental medicine.

[55]  M. Caligiuri,et al.  Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  R. Humphries,et al.  Hox Genes: From Leukemia to Hematopoietic Stem Cell Expansion , 2005, Annals of the New York Academy of Sciences.

[57]  G. Sauvageau,et al.  Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. , 2005, Blood.

[58]  Pu Zhang,et al.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. , 2004, Immunity.

[59]  R. Verhaak,et al.  Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.

[60]  A. Friedman,et al.  C/EBPαp30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding , 2004, Oncogene.

[61]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[62]  Unnur Thorsteinsdottir,et al.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.

[63]  D. Stéhelin,et al.  Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains , 1998, Oncogene.

[64]  W. Pear,et al.  Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia. , 2008, Blood cells, molecules & diseases.